Audrey Bernstein
CSO DUB Therapeutics
Seminars
Wednesday 28th January 2026
Leveraging an RNAi Solution for a Novel Integrin in Chronic Fibrosis
12:30 pm
- Leveraging self-delivering siRNA technology to silence a novel integrin target that drives the pathological switch to chronic fibrosis
- Unlocking regenerative healing by reversing myofibroblast persistence
- Validating a new treatment paradigm to demonstrate potent target knockdown and functional recovery in models of fibrotic disease
